Moneycontrol PRO
Upcoming Webinar:Watch a panel of experts discuss: Challenges of continuously evolving regulation for Cryptocurrency, on 7th July at 3pm. Register Now

business

Ideas For Profit | Gland Pharma trades at a discount to Syngene & Divi’s; Enough triggers to invest?

With the rising prevalence of chronic diseases and growth of biologics, MC Pro recommends holding Gland Pharma. Post the recent correction and downward adjustments in estimates, Gland Pharma is trading at 17x EV/EBITDA for FY24e. Here’s why it makes for a good investment bet.

LATEST VIDEOS

Watch More →

A collection of the most-viewed Moneycontrol videos.

Ideas for Profit

Watch More →

Indo Star, Federal Bank, Reliance, Campus, Blue Dart Are Stocks In Focus | Markets With Santo & CJ

Watch and Follow our leading shows

Sections
ISO 27001 - BSI Assurance Mark